Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01335776
Other study ID # RT735639
Secondary ID
Status Completed
Phase N/A
First received April 12, 2011
Last updated June 17, 2013
Start date September 2008
Est. completion date July 2012

Study information

Verified date June 2013
Source University of Calgary
Contact n/a
Is FDA regulated No
Health authority Canada: Canadian Institutes of Health Research
Study type Interventional

Clinical Trial Summary

Sleep disturbance in cancer patients is often overlooked despite its documented high prevalence and negative impact. There are few empirically validated non-pharmacological treatments for insomnia and many patients are unwilling to rely on sleeping medications. This study will determine whether Mindfulness-Based Stress Reduction (a program that teaches meditation and yoga) produces equivalent results with the additional benefits of reduced stress and mood disturbance, to an already established treatment for insomnia, Cognitive-Behavioral Therapy. This will allow for the expansion of treatment options for insomnia beyond what is currently available and improve quality of life for millions of cancer survivors.


Recruitment information / eligibility

Status Completed
Enrollment 111
Est. completion date July 2012
Est. primary completion date July 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- English speaking

- Non metastatic cancer

- 1 month post chemotherapy/radiation treatment (hormone treatment okay)

- Diagnosis of Primary or Secondary Insomnia

Exclusion Criteria:

- Presence of another sleep disorder

- Presence of another Axis I diagnosis (not in remission)

- Inability to attend at least 5 out of the 8 treatment sessions

- Randomization Refusal

- Previous participation in CBT-I or MBSR

- Shift work

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Mindfulness-Based Stress Reduction
This intervention is provided over the course of eight, weekly, 90 minute sessions, plus one 6 hour silent retreat.
Cognitive Behavior Therapy
This treatment is delivered to small groups over the course of 8 weekly, 90 minute sessions

Locations

Country Name City State
Canada Tom Baker Cancer Centre-Holy Cross Site Calgary Alberta

Sponsors (2)

Lead Sponsor Collaborator
University of Calgary Canadian Cancer Society Research Institute (CCSRI)

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Insomnia Severity from baseline to 3 months Baseline, Post-Treatment, 3 month follow up No
Secondary Change in objective measures of sleep using Wrist Actigraphy from baseline to 3 months Baseline, Post Treatment, 3 month follow up No
Secondary Change in subjective measures of sleep using Sleep Diaries from baseline to 3 months Baseline (one week), During treatment (7 weeks), Post Treatment (1 week), 3 month Follow up (1 week) No
Secondary Change in Pittsburgh Sleep Quality Index scores from baseline to 3 months Baseline, Post Treatment, 3 month follow up No
Secondary Change in Dysfunctional Attitudes and Beliefs about Sleep Scale scores from baseline to 3 months Baseline, Post Treatment, 3 month folllow up No
Secondary Change in Calgary Symptoms of Stress Inventory scores from baseline to 3 months Baseline, Post Treatment, 3 month folllow up No
Secondary Change in Five Facet Mindfulness Questionnaire scores from baseline to 3 months Baseline, Post Treatment, 3 month folllow up No
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

External Links